Nxstage Medical (NXTM) Tops Q3 EPS by 4c

Nxstage Medical (NASDAQ: NXTM) reported Q3 EPS of $0.00, $0.04 better than the analyst estimate of ($0.04). Revenue for the quarter came in at $92 million versus the consensus estimate of $89.82 million.

GUIDANCE:

Nxstage Medical sees FY2016 revenue of $360-365 million.

For earnings history and earnings-related data on Nxstage Medical (NXTM) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Newton Golf Company (NWTG) Reports Q2 Loss of $0.49
• Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c